# Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss

> **NCT01599130** · NA · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 60 (estimated)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Peginterferon alfa-2a

## Key facts

- **NCT ID:** NCT01599130
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01599130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01599130, "Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01599130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*